The purpose of this study is to evaluate the efficacy, safety, and drug levels of Deucravacitinib (BMS-986165) in adolescent participants with moderate to severe plaque psoriasis
The purpose of this study is to evaluate the efficacy, safety, and drug levels of Deucravacitinib (BMS-986165) in adolescent participants with moderate to severe plaque psoriasis
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
-
Local Institution - 0041, Birmingham, Alabama, United States, 35243
Local Institution - 0025, Fountain Valley, California, United States, 92708
Local Institution - 0090, Fremont, California, United States, 94538
Local Institution - 0214, Northridge, California, United States, 91325
Local Institution - 0077, Sacramento, California, United States, 95814
Local Institution - 0243, Walnut Creek, California, United States, 94598
Paradigm Clinical Research, LLC, Wheat Ridge, Colorado, United States, 80033
Local Institution - 0021, Clearwater, Florida, United States, 33756
Local Institution - 0185, Margate, Florida, United States, 33063
Local Institution - 0014, Miami Lakes, Florida, United States, 33016
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
12 Years to 17 Years
ALL
No
Bristol-Myers Squibb,
Bristol-Myers Squibb, STUDY_DIRECTOR, Bristol-Myers Squibb
2034-08-12